 |
|
| |
 |
Subject: |
|
 |
| Medications |
| |
 |
Content: |
|
|
Product(s) in general : Medications
Specific Item(s) : Ampicilline sodium. 500mg base powder for reconstitution
Beclomethasone dipropionate oral. 50mcg Inhaler
Beclomethasone dipropionate nasal. 50mcg Aerosol
Becomethasone Forten. 250mg Aerosol
Betamethasone (disodium phosphate). 4mg/ml injection
Cephalothin. 1g powder for reconstitution
Cephradine. 1g powder for reconstitution
Dexamethasone (acetate). 8mg/ml Suspension injection
Dexamethasone (phosphate). 4mg/ml Solution injection
Diclofenac Sodium. 75mg/ml Solution injection
Dipyrone. 1g/2ml Solution injection
Dipyrone sodium. 2,5g/5ml Solution injection
Gentamicin (Sulphate). 160mg/2ml Solution injection
Hydrocortisone. 100mg Solution injection
Hyoscine-N-buti bromide + Dypirone. (0,025=2,5)g/5ml Solution injection
Hyoscine-N-butil bromide. 20mg/nl Solution injection
Metoclopramide (Chlorhydrate). 10mg/2ml Solution injection
Oxacillin (sodium salt). 1 gr injection
Penicillin G Benzathine. 1¡¦ 200.000u.i. powder for reconstitution
Penicillin G Benzathine. 2¡¦ 400.000 u.i. powder for reconstitution
Penicillin G Procaine. 400.000 Ul powder or grains for reconstitution
Penicillin G Procaine. 800.000 u.i. powder for reconstitution
Penicillin G Sodium or Potassium crystals 1¡¦ 000,000 powder for reconstitution
Penicillin G Sodium or Potassium crystals 5¡¦ 000,000 powder for reconstitution
Salbutamol (Sulphate). 100 mcg/inhaler Aerosol
Others mainly in ampules presentation.
Product Features/Functions : Medications like antibiotics and so, mostly in ampules. Colombia¡¦s government requires medications to be imported, have GMP certification from USA, CANADA, Europe, Australia or JAPAN. Also is valid INVIMA¡¦s GMP certification (from Colombia). No other GMP certification is valid here.
Target Cost : Target cost is as per volume demanded. But should be aware that there are some China and India companies with medications in our market at a very low cost. |
|
|
| |
| 2013/11/9 |
| |
 |
Company Profile: |
|
|
| |
| |
|
| |
|
|
| |
| |
 |
|
